{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:09:05Z","timestamp":1793196545658,"version":"4.5.0"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05683-5","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T06:29:42Z","timestamp":1770359382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sulforaphane-Mediated Multitarget Therapeutic Effects in Methylmercury-Induced ALS-Like Pathology: Comparative Analysis and Multifaceted Approach to Neuroprotection and Systemic Recovery"],"prefix":"10.1007","volume":"63","author":[{"given":"Ritam","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0034-835X","authenticated-orcid":false,"given":"Sidharth","family":"Mehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanshyam","family":"Das Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajaram","family":"Samant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Tongra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"5683_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2024.108518","author":"R Sharma","year":"2024","unstructured":"Sharma R, Khan Z, Mehan S, Das Gupta G, Narula AS, Elsevier B.V. (2024) Unraveling the multifaceted insights into amyotrophic lateral sclerosis: genetic underpinnings, pathogenesis, and therapeutic horizons. Mutat Res Rev Mutat Res. https:\/\/doi.org\/10.1016\/j.mrrev.2024.108518","journal-title":"Mutat Res Rev Mutat Res"},{"key":"5683_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00612-2","author":"RJ Mead","year":"2023","unstructured":"Mead RJ, Shan N, Reiser HJ, Marshall F, Shaw PJ (2023) Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nat Rev Drug Discov. https:\/\/doi.org\/10.1038\/s41573-022-00612-2","journal-title":"Nat Rev Drug Discov"},{"key":"5683_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00465-8","author":"SA Goutman","year":"2022","unstructured":"Goutman SA, Hardiman O, Al-Chalabi A, Chi\u00f3 A, Savelieff MG, Kiernan MC et al (2022) Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. Lancet Neurol. https:\/\/doi.org\/10.1016\/S1474-4422(21)00465-8","journal-title":"Lancet Neurol"},{"key":"5683_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05328-6","author":"A Shandilya","year":"2021","unstructured":"Shandilya A, Mehan S (2021) Dysregulation of IGF-1\/GLP-1 signaling in the progression of ALS: potential target activators and influences on neurological dysfunctions. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-021-05328-6","journal-title":"Neurol Sci"},{"key":"5683_CR5","doi-asserted-by":"publisher","unstructured":"\u00a0Alam M, Yadav RK, Minj E, Tiwari A, Mehan S (2021) Exploring molecular approaches in amyotrophic lateral sclerosis: drug targets from clinical and pre-clinical findings. Curr Mol Pharmacol 14(3), 263\u2013280.\nhttps:\/\/doi.org\/10.2174\/1566524020666200427214356","DOI":"10.2174\/1566524020666200427214356"},{"key":"5683_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01272-7","author":"EL Feldman","year":"2022","unstructured":"Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ et al (2022) Amyotrophic lateral sclerosis. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(22)01272-7","journal-title":"Lancet"},{"key":"5683_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/toxics9060142","author":"H Cheng","year":"2021","unstructured":"Cheng H, Yang B, Ke T, Li S, Yang X, Aschner M et al (2021) Mechanisms of metal-induced mitochondrial dysfunction in neurological disorders. Toxics. https:\/\/doi.org\/10.3390\/toxics9060142","journal-title":"Toxics"},{"key":"5683_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s10534-018-0124-4","author":"R Pamphlett","year":"2018","unstructured":"Pamphlett R, Kum Jew S (2018) Inorganic mercury in human astrocytes, oligodendrocytes, corticomotoneurons and the locus ceruleus: implications for multiple sclerosis, neurodegenerative disorders and gliomas. Biometals. https:\/\/doi.org\/10.1007\/s10534-018-0124-4","journal-title":"Biometals"},{"key":"5683_CR9","doi-asserted-by":"publisher","DOI":"10.1080\/10715762.2018.1546852","author":"W Liu","year":"2019","unstructured":"Liu W, Yang T, Xu Z, Xu B, Deng Y (2019) Methyl-mercury induces apoptosis through ROS-mediated endoplasmic reticulum stress and mitochondrial apoptosis pathways activation in rat cortical neurons. Free Radic Res. https:\/\/doi.org\/10.1080\/10715762.2018.1546852","journal-title":"Free Radic Res"},{"key":"5683_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22063101","author":"JP Novo","year":"2021","unstructured":"Novo JP, Martins B, Raposo RS, Pereira FC, Ori\u00e1 RB, Malva JO et al (2021) Cellular and molecular mechanisms mediating methylmercury neurotoxicity and neuroinflammation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22063101","journal-title":"Int J Mol Sci"},{"key":"5683_CR11","doi-asserted-by":"publisher","unstructured":"Santana LNDS, Bittencourt LO, Nascimento PC, Fernandes RM, Teixeira FB, Fernandes LMP, Freitas Silva MC, Nogueira LS, Amado LL, Crespo-Lopez ME, Maia CDSF, Lima RR (2019) Low doses of methylmercury exposure during adulthood in rats display oxidative stress, neurodegeneration in the motor cortex and lead to impairment of motor skills. Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 51, 19\u201327.\nhttps:\/\/doi.org\/10.1016\/j.jtemb.2018.09.004","DOI":"10.1016\/j.jtemb.2018.09.004"},{"key":"5683_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24050","author":"S Sharma","year":"2024","unstructured":"Sharma S, Mehan S, Khan Z, Gupta GD, Narula AS (2024) Icariin prevents methylmercury-induced experimental neurotoxicity: evidence from cerebrospinal fluid, blood plasma, brain samples, and in-silico investigations. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24050","journal-title":"Heliyon"},{"key":"5683_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-021-03366-2","author":"E Minj","year":"2021","unstructured":"Minj E, Upadhayay S, Mehan S (2021) Nrf2\/HO-1 signaling activator acetyl-11-keto-beta Boswellic acid (AKBA)-mediated neuroprotection in methyl mercury-induced experimental model of ALS. Neurochem Res. https:\/\/doi.org\/10.1007\/s11064-021-03366-2","journal-title":"Neurochem Res"},{"key":"5683_CR14","doi-asserted-by":"publisher","unstructured":"\u00a0Alam MM, Minj E, Yadav RK, Mehan S (2020) Neuroprotective potential of adenyl cyclase\/cAMP\/CREB and mitochondrial CoQ10 activator in amyotrophic lateral sclerosis rats. Curr Bioact Compd 17(5).\nhttps:\/\/doi.org\/10.2174\/1573407216999200723113054","DOI":"10.2174\/1573407216999200723113054"},{"key":"5683_CR15","doi-asserted-by":"publisher","DOI":"10.1177\/09603271221084276","author":"RK Yadav","year":"2022","unstructured":"Yadav RK, Mehan S, Sahu R, Kumar S, Khan A, Makeen HA et al (2022) Protective effects of apigenin on methylmercury-induced behavioral\/neurochemical abnormalities and neurotoxicity in rats. Hum Exp Toxicol. https:\/\/doi.org\/10.1177\/09603271221084276","journal-title":"Hum Exp Toxicol"},{"key":"5683_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27123878","author":"A Shandilya","year":"2022","unstructured":"Shandilya A, Mehan S, Kumar S, Sethi P, Narula AS, Alshammari A et al (2022) Activation of IGF-1\/GLP-1 signalling via 4-hydroxyisoleucine prevents motor neuron impairments in experimental ALS-rats exposed to methylmercury-induced neurotoxicity. Molecules. https:\/\/doi.org\/10.3390\/molecules27123878","journal-title":"Molecules"},{"key":"5683_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2022.04.023","author":"R Sahu","year":"2022","unstructured":"Sahu R, Mehan S, Kumar S, Prajapati A, Alshammari A, Alharbi M et al (2022) Effect of alpha-mangostin in the prevention of behavioural and neurochemical defects in methylmercury-induced neurotoxicity in experimental rats. Toxicol Rep. https:\/\/doi.org\/10.1016\/j.toxrep.2022.04.023","journal-title":"Toxicol Rep"},{"key":"5683_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2025.115545","author":"R Rana","year":"2025","unstructured":"Rana R, Mukherjee R, Mehan S, khan Z, Das Gupta G, Narula AS (2025) Molecular mechanisms of neuroprotection: the interplay of Klotho, SIRT-1, Nrf2, and HO-1 in neurological health. Behav Brain Res. https:\/\/doi.org\/10.1016\/j.bbr.2025.115545","journal-title":"Behav Brain Res"},{"key":"5683_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00491-x","author":"NK Campbell","year":"2021","unstructured":"Campbell NK, Fitzgerald HK, Dunne A (2021) Regulation of inflammation by the antioxidant haem oxygenase 1. Nat Rev Immunol. https:\/\/doi.org\/10.1038\/s41577-020-00491-x","journal-title":"Nat Rev Immunol"},{"key":"5683_CR20","first-page":"403","volume":"15","author":"A Dhiman","year":"2025","unstructured":"Dhiman A, Choudhary D, Mehan S, Maurya PK, Sharma AK, Kumar A et al (2025Jun) Therapeutic potential of Baicalin against experimental obsessive compulsive disorder: evidence from CSF, blood plasma, and brain analysis. J Neuroimmunol 15:403","journal-title":"J Neuroimmunol"},{"key":"5683_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05001-5","author":"AK Gupta","year":"2025","unstructured":"Gupta AK, Gupta S, Mehan S, Khan Z, Das Gupta G, Narula AS (2025) Exploring the connection between BDNF\/TrkB and AC\/cAMP\/PKA\/CREB signaling pathways: potential for neuroprotection and therapeutic targets for neurological disorders. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-025-05001-5","journal-title":"Mol Neurobiol"},{"key":"5683_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-023-03727-8","author":"NH Ali","year":"2024","unstructured":"Ali NH, Al-kuraishy HM, Al-Gareeb AI, Alnaaim SA, Saad HM, Batiha GES (2024) The molecular pathway of p75 neurotrophin receptor (p75NTR) in Parkinson\u2019s disease: the way of new inroads. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-023-03727-8","journal-title":"Mol Neurobiol"},{"key":"5683_CR23","doi-asserted-by":"publisher","unstructured":"Khan MN, Choudhary D, Mehan S, Khan Z, Gupta GD, Narula AS (2025) Molecular mechanisms of GDNF\/GFRA1\/RET and PI3K\/AKT\/ERK signaling interplay in neuroprotection: Therapeutic strategies for treating neurological disorders. Neuropeptides, 111, 102516. https:\/\/doi.org\/10.1016\/j.npep.2025.102516","DOI":"10.1016\/j.npep.2025.102516"},{"key":"5683_CR24","doi-asserted-by":"crossref","unstructured":"Mukherjee R, Rana R, Mehan S, Khan Z, Das Gupta G, Narula AS, et al (2025) Investigating the interplay between the Nrf2\/Keap1\/HO-1\/SIRT-1 pathway and the p75NTR\/PI3K\/Akt\/MAPK cascade in neurological disorders: mechanistic insights and therapeutic innovations. Mol Neurobiol. Springer","DOI":"10.1007\/s12035-025-04725-8"},{"key":"5683_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/toxins14110733","author":"W Xu","year":"2022","unstructured":"Xu W, Zheng H, Fu Y, Gu Y, Zou H, Yuan Y et al (2022) Role of PI3K\/Akt-mediated Nrf2\/HO-1 signaling pathway in resveratrol alleviation of zearalenone-induced oxidative stress and apoptosis in TM4 cells. Toxins (Basel). https:\/\/doi.org\/10.3390\/toxins14110733","journal-title":"Toxins (Basel)"},{"key":"5683_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00828-5","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW et al (2021) Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-021-00828-5","journal-title":"Signal Transduct Target Ther"},{"key":"5683_CR27","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.6962","author":"X Jin","year":"2017","unstructured":"Jin X, Xu Z, Fan R, Wang C, Ji W, Ma Y et al (2017) HO-1 alleviates cholesterol-induced oxidative stress through activation of Nrf2\/ERK and inhibition of PI3K\/AKT pathways in endothelial cells. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2017.6962","journal-title":"Mol Med Rep"},{"key":"5683_CR28","doi-asserted-by":"crossref","unstructured":"Gupta S, Gupta AK, Mehan S, khan Z, Gupta G Das, Narula AS (2025) Disruptions in cellular communication: molecular interplay between glutamate\/NMDA signalling and MAPK pathways in neurological disorders. Neuroscience. Elsevier Ltd","DOI":"10.1016\/j.neuroscience.2025.01.021"},{"key":"5683_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-021-00401-6","author":"A Singh","year":"2021","unstructured":"Singh A, Upadhayay S, Mehan S (2021) Understanding abnormal c-JNK\/p38MAPK signaling overactivation involved in the progression of multiple sclerosis: possible therapeutic targets and impact on neurodegenerative diseases. Neurotox Res. https:\/\/doi.org\/10.1007\/s12640-021-00401-6","journal-title":"Neurotox Res"},{"key":"5683_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddaa282","author":"CK Hui","year":"2020","unstructured":"Hui CK, Dedkova EN, Montgomery C, Cortopassi G (2020) Dimethyl fumarate dose-dependently increases mitochondrial gene expression and function in muscle and brain of Friedreich\u2019s ataxia model mice. Hum Mol Genet. https:\/\/doi.org\/10.1093\/hmg\/ddaa282","journal-title":"Hum Mol Genet"},{"key":"5683_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2017.12.011","author":"YL Wu","year":"2018","unstructured":"Wu YL, Chang JC, Lin WY, Li CC, Hsieh M, Chen HW et al (2018) Caffeic acid and resveratrol ameliorate cellular damage in cell and Drosophila models of spinocerebellar ataxia type 3 through upregulation of Nrf2 pathway. Free Radic Biol Med. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.12.011","journal-title":"Free Radic Biol Med"},{"key":"5683_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/5698119","author":"M Cheng","year":"2024","unstructured":"Cheng M, Yuan C, Ju Y, Liu Y, Shi B, Yang Y et al (2024) Quercetin attenuates oxidative stress and apoptosis in brain tissue of APP\/PS1 double transgenic AD mice by regulating Keap1\/Nrf2\/HO-1 pathway to improve cognitive impairment. Behav Neurol. https:\/\/doi.org\/10.1155\/2024\/5698119","journal-title":"Behav Neurol"},{"key":"5683_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109698","author":"B Huang","year":"2023","unstructured":"Huang B, Hu G, Zong X, Yang S, He D, Gao X et al (2023) \u03b1-Cyperone protects dopaminergic neurons and inhibits neuroinflammation in LPS-induced Parkinson\u2019s disease rat model via activating Nrf2\/HO-1 and suppressing NF-\u03baB signaling pathway. Int Immunopharmacol. https:\/\/doi.org\/10.1016\/j.intimp.2023.109698","journal-title":"Int Immunopharmacol"},{"key":"5683_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/genes13081324","author":"S Upadhayay","year":"2022","unstructured":"Upadhayay S, Mehan S, Prajapati A, Sethi P, Suri M, Zawawi A et al (2022) Nrf2\/HO-1 signaling stimulation through acetyl-11-keto-beta-boswellic acid (AKBA) provides neuroprotection in ethidium bromide-induced experimental model of multiple sclerosis. Genes. https:\/\/doi.org\/10.3390\/genes13081324","journal-title":"Genes"},{"key":"5683_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2021.100051","author":"N Sharma","year":"2021","unstructured":"Sharma N, Upadhayay S, Shandilya A, Sahu R, Singh A, Rajkhowa B et al (2021) Neuroprotection by solanesol against ethidium bromide-induced multiple sclerosis-like neurobehavioral, molecular, and neurochemical alterations in experimental rats. Phytomedicine Plus. https:\/\/doi.org\/10.1016\/j.phyplu.2021.100051","journal-title":"Phytomedicine Plus"},{"key":"5683_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111736","author":"NA Khattab","year":"2024","unstructured":"Khattab NA, El-Kadem AH, Elblehi SS, Ahmed El-Mahdy N, El-Shitany NA (2024) The emerging role of \u03b17nAChRs\/caspase-3\/Nrf-2 signaling pathway in citicoline improved autistic behavior induced by thimerosal in mice. Int Immunopharmacol. https:\/\/doi.org\/10.1016\/j.intimp.2024.111736","journal-title":"Int Immunopharmacol"},{"key":"5683_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2020.12.009","author":"D Li","year":"2021","unstructured":"Li D, Bai X, Jiang Y, Cheng Y (2021) Butyrate alleviates PTZ-induced mitochondrial dysfunction, oxidative stress and neuron apoptosis in mice via Keap1\/Nrf2\/HO-1 pathway. Brain Res Bull. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.12.009","journal-title":"Brain Res Bull"},{"key":"5683_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111657","author":"MM Almostafa","year":"2024","unstructured":"Almostafa MM, Mohamed ME, Younis NS (2024) Ameliorative effects of vanillin against pentylenetetrazole-induced epilepsy and associated memory loss in mice: the role of Nrf2\/HO-1\/NQO1 and HMGB1\/RAGE\/TLR4\/NF\u03baB pathways. Int Immunopharmacol. https:\/\/doi.org\/10.1016\/j.intimp.2024.111657","journal-title":"Int Immunopharmacol"},{"key":"5683_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2023.08.001","author":"P Sethi","year":"2023","unstructured":"Sethi P, Mehan S, Khan Z, Chhabra S (2023) Acetyl-11-keto-beta boswellic acid (AKBA) modulates CSTC-pathway by activating SIRT-1\/Nrf2-HO-1 signalling in experimental rat model of obsessive-compulsive disorder: evidenced by CSF, blood plasma and histopathological alterations. Neurotoxicology. https:\/\/doi.org\/10.1016\/j.neuro.2023.08.001","journal-title":"Neurotoxicology"},{"key":"5683_CR40","doi-asserted-by":"publisher","unstructured":"Rajkhowa B, Mehan S, Sethi P, Prajapati A (2022) Activation of SIRT-1 Signalling in the Prevention of Bipolar Disorder and Related Neurocomplications: Target Activators and Influences on Neurological Dysfunctions. Neurotoxicity Research, 40(2), 670 686. https:\/\/doi.org\/10.1007\/s12640-022-00480-z","DOI":"10.1007\/s12640-022-00480-z"},{"key":"5683_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2022.11.078","author":"Z Wei","year":"2023","unstructured":"Wei Z, Yang C, Feng K, Guo S, Huang Z, Wang Y et al (2023) P75NTR enhances cognitive dysfunction in a mouse Alzheimer\u2019s disease model by inhibiting microRNA-210-3p-mediated PCYT2 through activation of NF-\u03baB. Int J Biol Macromol. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.11.078","journal-title":"Int J Biol Macromol"},{"key":"5683_CR42","doi-asserted-by":"publisher","unstructured":"Wang Y, Lin Y, Wang L, Zhan H, Luo X, Zeng Y, Wu W, Zhang X, Wang F (2020) TREM2 ameliorates neuroinflammatory response and cognitive impairment via PI3K\/AKT\/FoxO3a signaling pathway in Alzheimer's disease mice. Aging, 12(20), 20862\u201320879. https:\/\/doi.org\/10.18632\/aging.104104","DOI":"10.18632\/aging.104104"},{"key":"5683_CR43","doi-asserted-by":"publisher","DOI":"10.18632\/aging.202181","author":"W Dong","year":"2021","unstructured":"Dong W, Luo B, Qiu C, Jiang X, Shen B, Zhang L et al (2021) TRIM3 attenuates apoptosis in Parkinson\u2019s disease via activating PI3K\/AKT signal pathway. Aging. https:\/\/doi.org\/10.18632\/aging.202181","journal-title":"Aging"},{"key":"5683_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113740","author":"Z Liu","year":"2021","unstructured":"Liu Z, Yan A, Zhao J, Yang S, Song L, Liu Z (2021) The p75 neurotrophin receptor as a novel intermediate in L-dopa-induced dyskinesia in experimental Parkinson\u2019s disease. Exp Neurol. https:\/\/doi.org\/10.1016\/j.expneurol.2021.113740","journal-title":"Exp Neurol"},{"key":"5683_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117110","author":"Y Dong","year":"2024","unstructured":"Dong Y, Liu Y, Tang J, Du J, Zhuang X, Tan S et al (2024) Zhisou powder displays therapeutic effect on chronic bronchitis through inhibiting PI3K\/Akt\/HIF-1\u03b1\/VEGFA signaling pathway and reprograming metabolic pathway of arachidonic acid. J Ethnopharmacol. https:\/\/doi.org\/10.1016\/j.jep.2023.117110","journal-title":"J Ethnopharmacol"},{"key":"5683_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-022-01026-0","author":"A Sharma","year":"2022","unstructured":"Sharma A, Bhalla S, Mehan S (2022) PI3K\/AKT\/mTOR signalling inhibitor chrysophanol ameliorates neurobehavioural and neurochemical defects in propionic acid-induced experimental model of autism in adult rats. Metab Brain Dis. https:\/\/doi.org\/10.1007\/s11011-022-01026-0","journal-title":"Metab Brain Dis"},{"key":"5683_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2016.10.015","author":"SS Valvassori","year":"2017","unstructured":"Valvassori SS, Dal-Pont GC, Resende WR, Jornada LK, Peterle BR, Machado AG et al (2017) Lithium and valproate act on the GSK-3\u03b2 signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain. Neuropharmacology. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.10.015","journal-title":"Neuropharmacology"},{"key":"5683_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2021.106679","author":"J Yang","year":"2021","unstructured":"Yang J, Feng G, Chen M, Wang S, Tang F, Zhou J et al (2021) Glucosamine promotes seizure activity via activation of the PI3K\/Akt pathway in epileptic rats. Epilepsy Res. https:\/\/doi.org\/10.1016\/j.eplepsyres.2021.106679","journal-title":"Epilepsy Res"},{"key":"5683_CR49","doi-asserted-by":"publisher","unstructured":"Pottoo FH, Salahuddin M, Khan FA, Alsaeed WJ, Albaqshi BT, Rahman JU, Gomaa MS, Salama I, Alomary MN, Beigh S (2023) Therapeutic enhancing potential of piracetam with diethylstilbestrol in prevention of grand-mal seizures in rats: inhibition of PI3K\/Akt\/mTOR signaling pathway and IL-1\u03b2, IL-6, TNF-\u03b1 cytokines levels. European Rev Med Pharmacol Sci 27(10), 4735\u20134751. https:\/\/doi.org\/10.26355\/eurrev_202305_32485","DOI":"10.26355\/eurrev_202305_32485"},{"key":"5683_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-017-0798-6","author":"T Ali","year":"2018","unstructured":"Ali T, Kim T, Rehman SU, Khan MS, Amin FU, Khan M et al (2018) Natural dietary supplementation of anthocyanins via PI3K\/Akt\/Nrf2\/HO-1 pathways mitigate oxidative stress, neurodegeneration, and memory impairment in a mouse model of Alzheimer\u2019s disease. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-017-0798-6","journal-title":"Mol Neurobiol"},{"key":"5683_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-019-00805-5","author":"NH Sayed","year":"2020","unstructured":"Sayed NH, Fathy N, Kortam MA, Rabie MA, Mohamed AF, Kamel AS (2020) Vildagliptin attenuates Huntington\u2019s disease through activation of GLP-1 receptor\/PI3K\/Akt\/BDNF pathway in 3-nitropropionic acid rat model. Neurotherapeutics. https:\/\/doi.org\/10.1007\/s13311-019-00805-5","journal-title":"Neurotherapeutics"},{"key":"5683_CR52","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2018.1562286","author":"H Dai","year":"2019","unstructured":"Dai H, Wang P, Mao H, Mao X, Tan S, Chen Z (2019) Dynorphin activation of kappa opioid receptor protects against epilepsy and seizure-induced brain injury via PI3K\/Akt\/Nrf2\/HO-1 pathway. Cell Cycle. https:\/\/doi.org\/10.1080\/15384101.2018.1562286","journal-title":"Cell Cycle"},{"key":"5683_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.00096","author":"T Ali","year":"2020","unstructured":"Ali T, Hao Q, Ullah N, Rahman SU, Shah FA, He K et al (2020) Melatonin act as an antidepressant via attenuation of neuroinflammation by targeting Sirt1\/Nrf2\/HO-1 signaling. Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2020.00096","journal-title":"Front Mol Neurosci"},{"key":"5683_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2021.100139","author":"A Singh","year":"2021","unstructured":"Singh A, Upadhayay S, Mehan S (2021) Inhibition of c-JNK\/p38MAPK signaling pathway by apigenin prevents neurobehavioral and neurochemical defects in ethidium bromide-induced experimental model of multiple sclerosis in rats: evidence from CSF, blood plasma and brain samples. Phytomedicine Plus. https:\/\/doi.org\/10.1016\/j.phyplu.2021.100139","journal-title":"Phytomedicine Plus"},{"key":"5683_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6673967","author":"H Jiang","year":"2021","unstructured":"Jiang H, Ashraf GM, Liu M, Zhao K, Wang Y, Wang L et al (2021) Tilianin ameliorates cognitive dysfunction and neuronal damage in rats with vascular dementia via p-CaMKII\/ERK\/CREB and ox-CaMKII-dependent MAPK\/NF- \u03ba B pathways. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2021\/6673967","journal-title":"Oxid Med Cell Longev"},{"key":"5683_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2019.05.041","author":"Y Li","year":"2019","unstructured":"Li Y, Wang B, Liu C, Zhu X, Zhang P, Yu H et al (2019) Inhibiting c-Jun N-terminal kinase (JNK)-mediated apoptotic signaling pathway in PC12 cells by a polysaccharide (CCP) from Coptis chinensis against amyloid-\u03b2 (A\u03b2)-induced neurotoxicity. Int J Biol Macromol. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.05.041","journal-title":"Int J Biol Macromol"},{"key":"5683_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.13709","author":"L Guo","year":"2022","unstructured":"Guo L, Li Y, Li W, Qiu J, Du J, Wang L et al (2022) Shikonin ameliorates oxidative stress and neuroinflammation via the Akt\/ERK\/JNK\/NF-\u03baB signalling pathways in a model of Parkinson\u2019s disease. Clin Exp Pharmacol Physiol. https:\/\/doi.org\/10.1111\/1440-1681.13709","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"5683_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109885","author":"Y Xiong","year":"2023","unstructured":"Xiong Y, Chen J, Lv M, Wang F, Zhang H, Tang B et al (2023) Thymol improves autism-like behaviour in VPA-induced ASD rats through the Pin1\/p38 MAPK pathway. Int Immunopharmacol. https:\/\/doi.org\/10.1016\/j.intimp.2023.109885","journal-title":"Int Immunopharmacol"},{"key":"5683_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22627","author":"MA Kortam","year":"2021","unstructured":"Kortam MA, Ali BM, Fathy N (2021) The deleterious effect of stress-induced depression on rat liver: protective role of resveratrol and dimethyl fumarate via inhibiting the MAPK\/ERK\/JNK pathway. J Biochem Mol Toxicol. https:\/\/doi.org\/10.1002\/jbt.22627","journal-title":"J Biochem Mol Toxicol"},{"key":"5683_CR60","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2023.12932","author":"Z Luo","year":"2023","unstructured":"Luo Z, Xu M, Zhang L, Zhang H, Xu Z, Xu Z (2023) Glycyrrhizin regulates the HMGB1\/P38MAPK signalling pathway in status epilepticus. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2023.12932","journal-title":"Mol Med Rep"},{"key":"5683_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2020.108586","author":"S Saad El-Din","year":"2020","unstructured":"Saad El-Din S, Rashed L, Medhat E, Emad Aboulhoda B, Desoky Badawy A, Mohammed ShamsEldeen A et al (2020) Active form of vitamin D analogue mitigates neurodegenerative changes in Alzheimer\u2019s disease in rats by targeting Keap1\/Nrf2 and MAPK-38p\/ERK signaling pathways. Steroids. https:\/\/doi.org\/10.1016\/j.steroids.2020.108586","journal-title":"Steroids"},{"key":"5683_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2019.114617","author":"J Ren","year":"2019","unstructured":"Ren J, Yuan L, Wang W, Zhang M, Wang Q, Li S et al (2019) Tricetin protects against 6-OHDA-induced neurotoxicity in Parkinson\u2019s disease model by activating Nrf2\/HO-1 signaling pathway and preventing mitochondria-dependent apoptosis pathway. Toxicol Appl Pharmacol. https:\/\/doi.org\/10.1016\/j.taap.2019.114617","journal-title":"Toxicol Appl Pharmacol"},{"key":"5683_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01836-y","author":"H Bian","year":"2020","unstructured":"Bian H, Wang G, Huang J, Liang L, Zheng Y, Wei Y et al (2020) Dihydrolipoic acid protects against lipopolysaccharide-induced behavioral deficits and neuroinflammation via regulation of Nrf2\/HO-1\/NLRP3 signaling in rat. J Neuroinflammation. https:\/\/doi.org\/10.1186\/s12974-020-01836-y","journal-title":"J Neuroinflammation"},{"key":"5683_CR64","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-019-09681-2","author":"PB Rosa","year":"2019","unstructured":"Rosa PB, Bettio LEB, Neis VB, Moretti M, Werle I, Leal RB et al (2019) The antidepressant-like effect of guanosine is dependent on GSK-3\u03b2 inhibition and activation of MAPK\/ERK and Nrf2\/heme oxygenase-1 signaling pathways. Purinergic Signal. https:\/\/doi.org\/10.1007\/s11302-019-09681-2","journal-title":"Purinergic Signal"},{"key":"5683_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108380","author":"J Wen","year":"2021","unstructured":"Wen J, Li S, Zheng C, Wang F, Luo Y, Wu L et al (2021) Tetramethylpyrazine nitrone improves motor dysfunction and pathological manifestations by activating the PGC-1\u03b1\/Nrf2\/HO-1 pathway in ALS mice. Neuropharmacology. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108380","journal-title":"Neuropharmacology"},{"key":"5683_CR66","doi-asserted-by":"publisher","unstructured":"Yun YC, Jeong SG, Kim SH, Cho GW (2019) Reduced sirtuin 1\/adenosine monophosphate-activated protein kinase in amyotrophic lateral sclerosis patient-derived mesenchymal stem cells can be restored by resveratrol. J Tissue Eng Regen Med 13(1), 110\u2013115. https:\/\/doi.org\/10.1002\/term.2776","DOI":"10.1002\/term.2776"},{"key":"5683_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-021-00867-7","author":"J Wang","year":"2021","unstructured":"Wang J, Tierney L, Mann R, Lonsway T, Walker CL (2021) Bisperoxovanadium promotes motor neuron survival and neuromuscular innervation in amyotrophic lateral sclerosis. Mol Brain. https:\/\/doi.org\/10.1186\/s13041-021-00867-7","journal-title":"Mol Brain"},{"key":"5683_CR68","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-022-03013-z","author":"Y Qi","year":"2022","unstructured":"Qi Y, Yang C, Zhao H, Deng Z, Xu J, Liang W et al (2022) Neuroprotective effect of sonic hedgehog mediated PI3K\/AKT pathway in amyotrophic lateral sclerosis model mice. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-022-03013-z","journal-title":"Mol Neurobiol"},{"key":"5683_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05430-w","author":"R Jia","year":"2017","unstructured":"Jia R, Shepheard S, Jin J, Hu F, Zhao X, Xue L et al (2017) Urinary extracellular domain of neurotrophin receptor p75 as a biomarker for amyotrophic lateral sclerosis in a Chinese cohort. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-017-05430-w","journal-title":"Sci Rep"},{"key":"5683_CR70","volume":"1","author":"R Sharma","year":"2024","unstructured":"Sharma R, Mehan S, Khan Z, Das Gupta G, Narula AS (2024) Therapeutic potential of oleanolic acid in modulation of PI3K\/Akt\/mTOR\/STAT-3\/GSK-3\u03b2 signaling pathways and neuroprotection against methylmercury-induced neurodegeneration. Neurochem Int 1:180","journal-title":"Neurochem Int"},{"key":"5683_CR71","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1799-22.2023","author":"TG Sahana","year":"2023","unstructured":"Sahana TG, Chase KJ, Liu F, Lloyd TE, Rossoll W, Zhang K (2023) c-Jun N-terminal kinase promotes stress granule assembly and neurodegeneration in C9orf72-mediated ALS and FTD. J Neurosci. https:\/\/doi.org\/10.1523\/JNEUROSCI.1799-22.2023","journal-title":"J Neurosci"},{"key":"5683_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-019-0475-y","author":"J Mitra","year":"2019","unstructured":"Mitra J, Hegde PM, Hegde ML (2019) Loss of endosomal recycling factor RAB11 coupled with complex regulation of MAPK\/ERK\/AKT signaling in postmortem spinal cord specimens of sporadic amyotrophic lateral sclerosis patients. Mol Brain. https:\/\/doi.org\/10.1186\/s13041-019-0475-y","journal-title":"Mol Brain"},{"key":"5683_CR73","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2018.3860","author":"SF Kan","year":"2018","unstructured":"Kan SF, Wang J, Sun GX (2018) Sulforaphane regulates apoptosis- and proliferation-related signaling pathways and synergizes with cisplatin to suppress human ovarian cancer. Int J Mol Med. https:\/\/doi.org\/10.3892\/ijmm.2018.3860","journal-title":"Int J Mol Med"},{"key":"5683_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2011.200","author":"GVK Senanayake","year":"2012","unstructured":"Senanayake GVK, Banigesh A, Wu L, Lee P, Juurlink BHJ (2012) The dietary phase 2 protein inducer sulforaphane can normalize the kidney epigenome and improve blood pressure in hypertensive rats. Am J Hypertens. https:\/\/doi.org\/10.1038\/ajh.2011.200","journal-title":"Am J Hypertens"},{"key":"5683_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.154002","author":"Y Sun","year":"2020","unstructured":"Sun Y, Zhou S, Guo H, Zhang J, Ma T, Zheng Y et al (2020) Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function. Metabolism. https:\/\/doi.org\/10.1016\/j.metabol.2019.154002","journal-title":"Metabolism"},{"key":"5683_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsi.2023.109135","author":"J Ma","year":"2023","unstructured":"Ma J, Wang B, Pu C, Chang K, Cheng Y, Sun R et al (2023) Protective effects of sulforaphane on inflammation, oxidative stress and intestinal dysbacteriosis induced by triphenyltin in Cyprinus carpio haematopterus. Fish Shellfish Immunol. https:\/\/doi.org\/10.1016\/j.fsi.2023.109135","journal-title":"Fish Shellfish Immunol"},{"key":"5683_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.fshw.2021.07.014","author":"Y Sun","year":"2022","unstructured":"Sun Y, Tang J, Li C, Liu J, Liu H (2022) Sulforaphane attenuates dextran sodium sulphate induced intestinal inflammation via IL-10\/STAT3 signaling mediated macrophage phenotype switching. Food Sci Hum Wellness. https:\/\/doi.org\/10.1016\/j.fshw.2021.07.014","journal-title":"Food Sci Hum Wellness"},{"key":"5683_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175066","author":"AI Ashmawy","year":"2022","unstructured":"Ashmawy AI, El-Abhar HS, Abdallah DM, Ali MA (2022) Chloroquine modulates the sulforaphane anti-obesity mechanisms in a high-fat diet model: role of JAK-2\/ STAT-3\/ SOCS-3 pathway. Eur J Pharmacol. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175066","journal-title":"Eur J Pharmacol"},{"key":"5683_CR79","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-022-09776-0","author":"G Ibrahim Fouad","year":"2023","unstructured":"Ibrahim Fouad G (2023) Sulforaphane, an Nrf-2 agonist, modulates oxidative stress and inflammation in a rat model of cuprizone-induced cardiotoxicity and hepatotoxicity. Cardiovasc Toxicol. https:\/\/doi.org\/10.1007\/s12012-022-09776-0","journal-title":"Cardiovasc Toxicol"},{"key":"5683_CR80","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4754195","author":"W Yang","year":"2020","unstructured":"Yang W, Liu Y, Xu QQ, Xian YF, Lin ZX (2020) Sulforaphene ameliorates neuroinflammation and hyperphosphorylated tau protein via regulating the PI3K\/Akt\/GSK-3 \u03b2 pathway in experimental models of Alzheimer\u2019s disease. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2020\/4754195","journal-title":"Oxid Med Cell Longev"},{"key":"5683_CR81","doi-asserted-by":"publisher","unstructured":"Zhang J, Zhang R, Zhan Z, Li X, Zhou F, Xing A, Jiang C, Chen Y, An L (2017) Beneficial Effects of Sulforaphane Treatment in Alzheimer's Disease May Be Mediated through Reduced HDAC1\/3 and Increased P75NTR Expression. Front Aging Neurosci 9, 121. https:\/\/doi.org\/10.3389\/fnagi.2017.00121","DOI":"10.3389\/fnagi.2017.00121"},{"key":"5683_CR82","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-022-02918-z","author":"C Zhou","year":"2022","unstructured":"Zhou C, Jung CG, Kim MJ, Watanabe A, Abdelhamid M, Taslima F et al (2022) Insulin deficiency increases Sirt2 level in streptozotocin-treated Alzheimer\u2019s disease-like mouse model: increased Sirt2 induces tau phosphorylation through ERK activation. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-022-02918-z","journal-title":"Mol Neurobiol"},{"key":"5683_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2018.04.017","author":"D Pu","year":"2018","unstructured":"Pu D, Zhao Y, Chen J, sun Y, Lv A, Zhu S et al (2018) Protective effects of sulforaphane on cognitive impairments and AD-like lesions in diabetic mice are associated with the upregulation of Nrf2 transcription activity. Neuroscience. https:\/\/doi.org\/10.1016\/j.neuroscience.2018.04.017","journal-title":"Neuroscience"},{"key":"5683_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2013.03.004","author":"F Morroni","year":"2013","unstructured":"Morroni F, Tarozzi A, Sita G, Bolondi C, Zolezzi Moraga JM, Cantelli-Forti G et al (2013) Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson\u2019s disease. Neurotoxicology. https:\/\/doi.org\/10.1016\/j.neuro.2013.03.004","journal-title":"Neurotoxicology"},{"key":"5683_CR85","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2011.731","author":"C Deng","year":"2012","unstructured":"Deng C, Tao R, Yu SZ, Jin H (2012) Sulforaphane protects against 6-hydroxydopamine-induced cytotoxicity by increasing expression of heme oxygenase-1 in a PI3K\/Akt-dependent manner. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2011.731","journal-title":"Mol Med Rep"},{"issue":"21","key":"5683_CR86","doi-asserted-by":"publisher","first-page":"9424","DOI":"10.18632\/aging.102394","volume":"11","author":"C Guo","year":"2019","unstructured":"Guo C, Zhu J, Wang J, Duan J, Ma S, Yin Y et al (2019Nov 6) Neuroprotective effects of protocatechuic aldehyde through PLK2\/p-GSK3\u03b2\/Nrf2 signaling pathway in both in vivo and in vitro models of Parkinson\u2019s disease. Aging 11(21):9424\u20139441","journal-title":"Aging"},{"key":"5683_CR87","doi-asserted-by":"publisher","unstructured":"\u00a0Zimmerman AW, Singh K, Connors SL, Liu H, Panjwani AA, Lee LC, Diggins E, Foley A, Melnyk S, Singh IN, James SJ, Frye RE, Fahey JW (2021) Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder. Mol Autism 12(1), 38. https:\/\/doi.org\/10.1186\/s13229-021-00447-5","DOI":"10.1186\/s13229-021-00447-5"},{"key":"5683_CR88","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.13016","author":"S Momtazmanesh","year":"2020","unstructured":"Momtazmanesh S, Amirimoghaddam-Yazdi Z, Moghaddam HS, Mohammadi MR, Akhondzadeh S (2020) Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: a randomized, double-blind, placebo-controlled clinical trial. Psychiatry Clin Neurosci. https:\/\/doi.org\/10.1111\/pcn.13016","journal-title":"Psychiatry Clin Neurosci"},{"key":"5683_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2013.10.002","author":"B Li","year":"2013","unstructured":"Li B, Cui W, Liu J, Li R, Liu Q, Xie XH et al (2013) Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice. Exp Neurol. https:\/\/doi.org\/10.1016\/j.expneurol.2013.10.002","journal-title":"Exp Neurol"},{"key":"5683_CR90","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300556","author":"J Geisel","year":"2014","unstructured":"Geisel J, Br\u00fcck J, Glocova I, Dengler K, Sinnberg T, Rothfuss O et al (2014) Sulforaphane protects from T cell\u2013mediated autoimmune disease by inhibition of IL-23 and IL-12 in dendritic cells. J Immunol. https:\/\/doi.org\/10.4049\/jimmunol.1300556","journal-title":"J Immunol"},{"issue":"4","key":"5683_CR91","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1007\/s12035-015-9230-2","volume":"53","author":"M Jang","year":"2016","unstructured":"Jang M, Cho IH (2016May 1) Sulforaphane ameliorates 3-nitropropionic acid-induced striatal toxicity by activating the Keap1-Nrf2-ARE pathway and inhibiting the MAPKs and NF-\u03baB pathways. Mol Neurobiol 53(4):2619\u20132635","journal-title":"Mol Neurobiol"},{"key":"5683_CR92","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-015-9643-y","author":"S Feng","year":"2017","unstructured":"Feng S, Xu Z, Wang F, Yang T, Liu W, Deng Y et al (2017) Sulforaphane prevents methylmercury-induced oxidative damage and excitotoxicity through activation of the Nrf2-ARE pathway. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-015-9643-y","journal-title":"Mol Neurobiol"},{"key":"5683_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2022.10.001","author":"Q Li","year":"2022","unstructured":"Li Q, Fadoul G, Ikonomovic M, Yang T, Zhang F (2022) Sulforaphane promotes white matter plasticity and improves long-term neurological outcomes after ischemic stroke via the Nrf2 pathway. Free Radic Biol Med. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.10.001","journal-title":"Free Radic Biol Med"},{"key":"5683_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/srep32206","author":"Q Zhou","year":"2016","unstructured":"Zhou Q, Chen B, Wang X, Wu L, Yang Y, Cheng X et al (2016) Sulforaphane protects against rotenone-induced neurotoxicity in vivo: involvement of the mTOR, Nrf2, and autophagy pathways. Sci Rep. https:\/\/doi.org\/10.1038\/srep32206","journal-title":"Sci Rep"},{"key":"5683_CR95","doi-asserted-by":"publisher","unstructured":"\u00a0Lynch DR, Chin MP, Delatycki MB, Subramony SH, Corti M, Hoyle JC, Boesch S, Nachbauer W, Mariotti C, Mathews KD, Giunti P, Wilmot G, Zesiewicz T, Perlman S, Goldsberry A, O'Grady M, Meyer CJ (2021) Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study). Ann Neurol 89(2), 212\u2013225.\nhttps:\/\/doi.org\/10.1002\/ana.25934","DOI":"10.1002\/ana.25934"},{"key":"5683_CR96","doi-asserted-by":"publisher","unstructured":"\u00a0Reisman SA, Gahir SS, Lee CI, Proksch JW, Sakamoto M, Ward KW (2019) Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primates. Drug design, Development and Therapy, 13, 1259\u20131270.\nhttps:\/\/doi.org\/10.2147\/DDDT.S193889","DOI":"10.2147\/DDDT.S193889"},{"key":"5683_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122261","author":"X Cui","year":"2023","unstructured":"Cui X, Zong S, Song W, Wang C, Liu Y, Zhang L et al (2023) Omaveloxolone ameliorates cognitive dysfunction in APP\/PS1 mice by stabilizing the STAT3 pathway. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2023.122261","journal-title":"Life Sci"},{"key":"5683_CR98","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4564471","author":"L Hu","year":"2022","unstructured":"Hu L, Cao Y, Chen H, Xu L, Yang Q, Zhou H et al (2022) The novel Nrf2 activator omaveloxolone regulates microglia phenotype and ameliorates secondary brain injury after intracerebral hemorrhage in mice. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2022\/4564471","journal-title":"Oxid Med Cell Longev"},{"key":"5683_CR99","doi-asserted-by":"publisher","unstructured":"\u00a0Madsen KL, Buch AE, Cohen BH, Falk MJ, Goldsberry A, Goldstein A, Karaa A, Koenig MK, Muraresku CC, Meyer C, O'Grady M, Scaglia F, Shieh PB, Vockley J, Zolkipli-Cunningham Z, Haller RG, Vissing J (2020) Safety and efficacy of omaveloxolone in patients with mitochondrial myopathy: MOTOR trial. Neurology, 94(7), e687\u2013e698.\nhttps:\/\/doi.org\/10.1212\/WNL.0000000000008861","DOI":"10.1212\/WNL.0000000000008861"},{"key":"5683_CR100","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.660","author":"DR Lynch","year":"2019","unstructured":"Lynch DR, Farmer J, Hauser L, Blair IA, Wang QQ, Mesaros C et al (2019) Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia. Ann Clin Transl Neurol. https:\/\/doi.org\/10.1002\/acn3.660","journal-title":"Ann Clin Transl Neurol"},{"key":"5683_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00209-5","author":"A Svenningsson","year":"2022","unstructured":"Svenningsson A, Frisell T, Burman J, Salzer J, Fink K, Hallberg S et al (2022) Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial. Lancet Neurol. https:\/\/doi.org\/10.1016\/S1474-4422(22)00209-5","journal-title":"Lancet Neurol"},{"key":"5683_CR102","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1603907113","author":"U Schulze-Topphoff","year":"2016","unstructured":"Schulze-Topphoff U, Varrin-Doyer M, Pekarek K, Spencer CM, Shetty A, Sagan SA et al (2016) Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.1603907113","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5683_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.105082","author":"IM Abd El-Fatah","year":"2021","unstructured":"Abd El-Fatah IM, Abdelrazek HMA, Ibrahim SM, Abdallah DM, El-Abhar HS (2021) Dimethyl fumarate abridged tauo-\/amyloidopathy in a D-galactose\/ovariectomy-induced Alzheimer\u2019s-like disease: modulation of AMPK\/SIRT-1, AKT\/CREB\/BDNF, AKT\/GSK-3\u03b2, adiponectin\/Adipo1R, and NF-\u03baB\/IL-1\u03b2\/ROS trajectories. Neurochem Int. https:\/\/doi.org\/10.1016\/j.neuint.2021.105082","journal-title":"Neurochem Int"},{"key":"5683_CR104","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2016.6800","author":"M Campolo","year":"2017","unstructured":"Campolo M, Casili G, Biundo F, Crupi R, Cordaro M, Cuzzocrea S et al (2017) The neuroprotective effect of dimethyl fumarate in an MPTP-mouse model of Parkinson\u2019s disease: involvement of reactive oxygen species\/nuclear factor-\u03baB\/nuclear transcription factor related to NF-E2. Antioxid Redox Signal. https:\/\/doi.org\/10.1089\/ars.2016.6800","journal-title":"Antioxid Redox Signal"},{"key":"5683_CR105","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51446","author":"S Vucic","year":"2021","unstructured":"Vucic S, Henderson RD, Mathers S, Needham M, Schultz D, Kiernan MC (2021) Safety and efficacy of dimethyl fumarate in ALS: randomised controlled study. Ann Clin Transl Neurol. https:\/\/doi.org\/10.1002\/acn3.51446","journal-title":"Ann Clin Transl Neurol"},{"key":"5683_CR106","doi-asserted-by":"crossref","unstructured":"Gilbert JW, Kennedy Z, Godinho BMDC, Summers A, Weiss A, Echeverria D, et al (2024) Identification of selective and non-selective C9ORF72 targeting in vivo active siRNAs. Mol Ther Nucleic Acids [Internet]. [cited 2024 Sep 29] 35(3). Available from: http:\/\/www.cell.com\/article\/S2162253124001781\/fulltext","DOI":"10.1016\/j.omtn.2024.102291"},{"key":"5683_CR107","doi-asserted-by":"crossref","unstructured":"Tsekrekou M, Giannakou M, Papanikolopoulou K, Skretas G (2024) Protein aggregation and therapeutic strategies in SOD1- and TDP-43- linked ALS. Front Mol Biosci [Internet]. [cited 2024 Sep 29] 11. Available from: https:\/\/www.pmc\/articles\/PMC11157337\/","DOI":"10.3389\/fmolb.2024.1383453"},{"issue":"126","key":"5683_CR108","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuint.2019.02.020","volume":"1","author":"K Hirayama","year":"2019","unstructured":"Hirayama K, Fujiwara Y, Terada T, Shimizu K, Wada K, Kabuta T (2019) Virtual screening identification of novel chemical inhibitors for aberrant interactions between pathogenic mutant SOD1 and tubulin. Neurochem Int 1(126):19\u201326","journal-title":"Neurochem Int"},{"key":"5683_CR109","doi-asserted-by":"crossref","unstructured":"Pinzi L, Rastelli G (2019) Molecular docking: shifting paradigms in drug discovery. Int J Mol Sci [Internet]. [cited 2024 Sep 29] 20(18). Available from: https:\/\/www.pmc\/articles\/PMC6769923\/","DOI":"10.3390\/ijms20184331"},{"key":"5683_CR110","doi-asserted-by":"crossref","unstructured":"Winkel AF, Engel CK, Margerie D, Kannt A, Szillat H, Glombik H, et al (2015) Characterization of RA839, a noncovalent small molecule binder to Keap1 and selective activator of Nrf2 signaling. J Biol Chem [Internet]. [cited 2024 Sep 29] 290(47):28446\u201355. Available from: http:\/\/www.jbc.org\/article\/S0021925820450161\/fulltext","DOI":"10.1074\/jbc.M115.678136"},{"key":"5683_CR111","doi-asserted-by":"crossref","unstructured":"Lad L, Schuller DJ, Shimizu H, Friedman J, Li H, Ortiz de Montellano PR, et al (2003) Comparison of the heme-free and -bound crystal structures of human heme oxygenase-1. J Biol Chem [Internet]. [cited 2024 Sep 29] 278(10):7834\u201343. Available from: http:\/\/www.jbc.org\/article\/S0021925820863923\/fulltext","DOI":"10.1074\/jbc.M211450200"},{"key":"5683_CR112","doi-asserted-by":"crossref","unstructured":"Dai H, Case AW, Riera TV, Considine T, Lee JE, Hamuro Y, et al (2015) Crystallographic structure of a small molecule SIRT1 activator-enzyme complex. NatCommun 6:1 [Internet]. [cited 2024 Sep 29] 6(1):1\u201310. Available from: https:\/\/www.nature.com\/articles\/ncomms8645","DOI":"10.1038\/ncomms8645"},{"key":"5683_CR113","doi-asserted-by":"crossref","unstructured":"Li X, Zhang D, Hannink M, Beamer LJ (2004) Crystal structure of the Kelch domain of human Keap1. J Biol Chem [Internet]. [cited 2024 Sep 29] 279(52):54750\u20138. Available from: http:\/\/www.jbc.org\/article\/S0021925819632424\/fulltext","DOI":"10.1074\/jbc.M410073200"},{"key":"5683_CR114","doi-asserted-by":"crossref","unstructured":"Gong Y, Cao P, Yu HJ, Jiang T (2008) Crystal structure of the neurotrophin-3 and p75NTR symmetrical complex. Nature 454:7205 [Internet]. [cited 2024 Sep 29] 454(7205):789\u201393. Available from: https:\/\/www.nature.com\/articles\/nature07089","DOI":"10.1038\/nature07089"},{"key":"5683_CR115","doi-asserted-by":"publisher","unstructured":"Zhao Y, Zhang X, Chen Y, Lu S, Peng Y, Wang X, et al (2014) Crystal structures of PI3K\u03b1 complexed with PI103 and its derivatives: new directions for inhibitors design. ACS Med Chem Lett [Internet]. [cited 2024 Sep 29] 5(2):138\u201342. Available from: https:\/\/doi.org\/10.1021\/ml400378e","DOI":"10.1021\/ml400378e"},{"key":"5683_CR116","doi-asserted-by":"publisher","unstructured":"Addie M, Ballard P, Buttar D, Crafter C, Currie G, Davies BR, et al (2013) Discovery of 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H- pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an orally bioavailable, potent inhibitor of Akt kinases. J Med Chem [Internet]. [cited 2024 Sep 29] 56(5):2059\u201373. Available from: https:\/\/doi.org\/10.1021\/jm301762v","DOI":"10.1021\/jm301762v"},{"key":"5683_CR117","doi-asserted-by":"crossref","unstructured":"Chaikuad A, Tacconi EMC, Zimmer J, Liang Y, Gray NS, Tarsounas M, et al (2014) A unique inhibitor binding site in ERK1\/2 is associated with slow binding kinetics. Nat Chem Biol 10:10 [Internet]. [cited 2024 Sep 29] 10(10):853\u201360. Available from: https:\/\/www.nature.com\/articles\/nchembio.1629","DOI":"10.1038\/nchembio.1629"},{"issue":"1","key":"5683_CR118","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.chembiol.2011.11.010","volume":"19","author":"T Zhang","year":"2012","unstructured":"Zhang T, Inesta-Vaquera F, Niepel M, Zhang J, Ficarro SB, MacHleidt T et al (2012Jan 27) Discovery of potent and selective covalent inhibitors of JNK. Chem Biol 19(1):140\u2013154","journal-title":"Chem Biol"},{"key":"5683_CR119","doi-asserted-by":"publisher","unstructured":"Watterson DM, Grum-Tokars VL, Roy SM, Schavocky JP, de Bradaric B, Bachstetter AD, et al (2013) Development of novel in vivo chemical probes to address CNS protein kinase involvement in synaptic dysfunction. PLoS One [Internet]. [cited 2024 Sep 29] 8(6):e66226. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0066226","DOI":"10.1371\/journal.pone.0066226"},{"key":"5683_CR120","doi-asserted-by":"crossref","unstructured":"Morris GM, Ruth H, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem [Internet]. [cited 2024 Sep 29] 30(16):2785. Available from: https:\/\/www.pmc\/articles\/PMC2760638\/","DOI":"10.1002\/jcc.21256"},{"key":"5683_CR121","doi-asserted-by":"crossref","unstructured":"Dallakyan S, Olson AJ (2015) Small-molecule library screening by docking with PyRx. Methods Mol Biol [Internet]. [cited 2024 Sep 29] 1263:243\u201350. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25618350\/","DOI":"10.1007\/978-1-4939-2269-7_19"},{"key":"5683_CR122","doi-asserted-by":"publisher","unstructured":"Kumar S, Shukla MK, Ali I, Abbas F, Verma R, Chandra G, et al (2023) In-silico and in-vitro identification of triazole based compounds as potential EGFR inhibitors targeting lung cancer. Mol Simul [Internet]. [cited 2024 Sep 29] 49(17):1614\u201331. Available from: https:\/\/doi.org\/10.1080\/08927022.2023.2256624","DOI":"10.1080\/08927022.2023.2256624"},{"key":"5683_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/srep41605","author":"AP Grzegorzewska","year":"2017","unstructured":"Grzegorzewska AP, Seta F, Han R, Czajka CA, Makino K, Stawski L et al (2017) Dimethyl fumarate ameliorates pulmonary arterial hypertension and lung fibrosis by targeting multiple pathways. Sci Rep. https:\/\/doi.org\/10.1038\/srep41605","journal-title":"Sci Rep"},{"key":"5683_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10091466","author":"JY Chien","year":"2021","unstructured":"Chien JY, Chou YY, Ciou JW, Liu FY, Huang SP (2021) The effects of two Nrf2 activators, bardoxolone methyl and omaveloxolone, on retinal ganglion cell survival during ischemic optic neuropathy. Antioxidants. https:\/\/doi.org\/10.3390\/antiox10091466","journal-title":"Antioxidants"},{"key":"5683_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.ibror.2020.03.001","author":"K Rajdev","year":"2020","unstructured":"Rajdev K, Siddiqui EM, Jadaun KS, Mehan S (2020) Neuroprotective potential of solanesol in a combined model of intracerebral and intraventricular hemorrhage in rats. IBRO Rep. https:\/\/doi.org\/10.1016\/j.ibror.2020.03.001","journal-title":"IBRO Rep"},{"key":"5683_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.npep.2022.102296","author":"S Bhalla","year":"2022","unstructured":"Bhalla S, Mehan S (2022) 4-hydroxyisoleucine mediated IGF-1\/GLP-1 signalling activation prevents propionic acid-induced autism-like behavioural phenotypes and neurochemical defects in experimental rats. Neuropeptides. https:\/\/doi.org\/10.1016\/j.npep.2022.102296","journal-title":"Neuropeptides"},{"key":"5683_CR127","doi-asserted-by":"publisher","unstructured":"Chhabra S, Mehan S, Khan Z, Gupta GD, Narula AS (2023) Matrine mediated neuroprotective potential in experimental multiple sclerosis: Evidence from CSF, blood markers, brain samples and in-silico investigations. J Neuroimmunol 384, 578200. https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578200","DOI":"10.1016\/j.jneuroim.2023.578200"},{"key":"5683_CR128","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.270316","author":"S Mehan","year":"2020","unstructured":"Mehan S, Rahi S, Tiwari A, Kapoor T, Rajdev K, Sharma R et al (2020) Adenylate cyclase activator forskolin alleviates intracerebroventricular propionic acid-induced mitochondrial dysfunction of autistic rats. Neural Regen Res. https:\/\/doi.org\/10.4103\/1673-5374.270316","journal-title":"Neural Regen Res"},{"key":"5683_CR129","doi-asserted-by":"publisher","unstructured":"Tiwari A, Khera R, Rahi S, Mehan S, Makeen HA, Khormi YH, Rehman MU, Khan A (2021) Neuroprotective Effect of \u03b1-Mangostin in the Ameliorating Propionic Acid-Induced Experimental Model of Autism in Wistar Rats. Brain Sci 11(3), 288. https:\/\/doi.org\/10.3390\/brainsci11030288","DOI":"10.3390\/brainsci11030288"},{"key":"5683_CR130","doi-asserted-by":"publisher","DOI":"10.2174\/1871527320666210126113848","author":"RK Yadav","year":"2021","unstructured":"Yadav RK, Minz E, Mehan S (2021) Understanding abnormal c-JNK\/p38MAPK signaling in amyotrophic lateral sclerosis: potential drug targets and influences on neurological disorders. CNS Neurol Disord Drug Targets. https:\/\/doi.org\/10.2174\/1871527320666210126113848","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"5683_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12030342","author":"R Gupta","year":"2022","unstructured":"Gupta R, Mehan S, Sethi P, Prajapati A, Alshammari A, Alharbi M et al (2022) Smo-Shh agonist purmorphamine prevents neurobehavioral and neurochemical defects in 8-OH-DPAT-induced experimental model of obsessive-compulsive disorder. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci12030342","journal-title":"Brain Sci"},{"key":"5683_CR132","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-023-03902-x","author":"S Kumar","year":"2024","unstructured":"Kumar S, Mehan S, Khan Z, Das Gupta G, Narula AS (2024) Guggulsterone selectively modulates STAT-3, mTOR, and PPAR-gamma signaling in a methylmercury-exposed experimental neurotoxicity: evidence from CSF, blood plasma, and brain samples. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-023-03902-x","journal-title":"Mol Neurobiol"},{"key":"5683_CR133","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27030889","author":"R Khera","year":"2022","unstructured":"Khera R, Mehan S, Bhalla S, Kumar S, Alshammari A, Alharbi M et al (2022) Guggulsterone mediated JAK\/STAT and PPAR-gamma modulation prevents neurobehavioral and neurochemical abnormalities in propionic acid-induced experimental model of autism. Molecules. https:\/\/doi.org\/10.3390\/molecules27030889","journal-title":"Molecules"},{"key":"5683_CR134","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-021-00691-x","author":"N Kumar","year":"2021","unstructured":"Kumar N, Sharma N, Khera R, Gupta R, Mehan S (2021) Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological alterations in rat brain. Metab Brain Dis. https:\/\/doi.org\/10.1007\/s11011-021-00691-x","journal-title":"Metab Brain Dis"},{"key":"5683_CR135","doi-asserted-by":"publisher","DOI":"10.1177\/09603271211013456","author":"S Rahi","year":"2021","unstructured":"Rahi S, Gupta R, Sharma A, Mehan S (2021) Smo-Shh signaling activator purmorphamine ameliorates neurobehavioral, molecular, and morphological alterations in an intracerebroventricular propionic acid-induced experimental model of autism. Hum Exp Toxicol. https:\/\/doi.org\/10.1177\/09603271211013456","journal-title":"Hum Exp Toxicol"},{"key":"5683_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2019.10.019","author":"R Sharma","year":"2019","unstructured":"Sharma R, Rahi S, Mehan S (2019) Neuroprotective potential of solanesol in intracerebroventricular propionic acid induced experimental model of autism: insights from behavioral and biochemical evidence. Toxicol Rep. https:\/\/doi.org\/10.1016\/j.toxrep.2019.10.019","journal-title":"Toxicol Rep"},{"key":"5683_CR137","doi-asserted-by":"publisher","DOI":"10.2174\/1567205017666201007120112","author":"P Duggal","year":"2020","unstructured":"Duggal P, Jadaun KS, Siqqiqui EM, Mehan S (2020) Investigation of low dose cabazitaxel potential as microtubule stabilizer in experimental model of Alzheimer\u2019s disease: restoring neuronal cytoskeleton. Curr Alzheimer Res. https:\/\/doi.org\/10.2174\/1567205017666201007120112","journal-title":"Curr Alzheimer Res"},{"key":"5683_CR138","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10112866","author":"TH Albekairi","year":"2022","unstructured":"Albekairi TH, Kamra A, Bhardwaj S, Mehan S, Giri A, Suri M et al (2022) Beta-boswellic acid reverses 3-nitropropionic acid-induced molecular, mitochondrial, and histopathological defects in experimental rat model of Huntington\u2019s disease. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10112866","journal-title":"Biomedicines"},{"key":"5683_CR139","doi-asserted-by":"publisher","unstructured":"Singh NK, Kotla S, Kumar R, Rao GN (2015) Cyclic AMP Response Element Binding Protein Mediates Pathological Retinal Neovascularization via Modulating DLL4-NOTCH1 Signaling. EBioMedicine, 2(11):1767-84. https:\/\/doi.org\/10.1016\/j.ebiom.2015.09.042","DOI":"10.1016\/j.ebiom.2015.09.042"},{"key":"5683_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115831","author":"A Giri","year":"2023","unstructured":"Giri A, Mehan S, Khan Z, Gupta G Das, Narula AS (2023) Melatonin-mediated IGF-1\/GLP-1 activation in experimental ocd rats: evidence from CSF, blood plasma, brain and in-silico investigations. Biochem Pharmacol. https:\/\/doi.org\/10.1016\/j.bcp.2023.115831","journal-title":"Biochem Pharmacol"},{"key":"5683_CR141","doi-asserted-by":"publisher","DOI":"10.4103\/ijp.IJP_11_18","author":"S Mehan","year":"2018","unstructured":"Mehan S, Monga V, Rani M, Dudi R, Ghimire K (2018) Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington\u2019s disease-like behavioral, biochemical, and cellular alterations: restoration of coenzyme-Q10-mediated mitochondrial dysfunction. Indian J Pharmacol. https:\/\/doi.org\/10.4103\/ijp.IJP_11_18","journal-title":"Indian J Pharmacol"},{"key":"5683_CR142","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-023-04082-9","author":"A Prajapati","year":"2024","unstructured":"Prajapati A, Mehan S, Khan Z, Chhabra S, Das Gupta G (2024) Purmorphamine, a Smo-Shh\/Gli activator, promotes sonic hedgehog-mediated neurogenesis and restores behavioural and neurochemical deficits in experimental model of multiple sclerosis. Neurochem Res. https:\/\/doi.org\/10.1007\/s11064-023-04082-9","journal-title":"Neurochem Res"},{"key":"5683_CR143","doi-asserted-by":"publisher","DOI":"10.1248\/jhs.51.220","author":"A Yasutake","year":"2005","unstructured":"Yasutake A, Nagano M, Nakano A (2005) Simple method for methylmercury estimation in biological samples using atomic absorption spectroscopy. J Health Sci. https:\/\/doi.org\/10.1248\/jhs.51.220","journal-title":"J Health Sci"},{"key":"5683_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00421","author":"SN Rai","year":"2017","unstructured":"Rai SN, Birla H, Singh SS, Zahra W, Patil RR, Jadhav JP et al (2017) Mucuna pruriens protects against MPTP intoxicated neuroinflammation in Parkinson\u2019s disease through NF-\u03baB\/pAKT signaling pathways. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2017.00421","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"5683_CR145","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1007\/s11064-021-03366-2","volume":"46","author":"E Minj","year":"2021","unstructured":"Minj E, Upadhayay S, Mehan S (2021Nov 1) Nrf2\/HO-1 signaling activator acetyl-11-keto-beta Boswellic acid (AKBA)-mediated neuroprotection in methyl mercury-induced experimental model of ALS. Neurochem Res 46(11):2867\u20132884","journal-title":"Neurochem Res"},{"key":"5683_CR146","doi-asserted-by":"publisher","unstructured":"\u00a0Kumar M, Mehan S, Kumar A, Sharma T, Khan Z, Tiwari A, Das Gupta G, Narula AS (2025) Therapeutic efficacy of Genistein in activation of neuronal AC\/cAMP\/CREB\/PKA and mitochondrial ETC-Complex pathways in experimental model of autism: Evidence from CSF, blood plasma and brain analysis. Brain Res 1846, 149251.\nhttps:\/\/doi.org\/10.1016\/j.brainres.2024.149251","DOI":"10.1016\/j.brainres.2024.149251"},{"key":"5683_CR147","doi-asserted-by":"crossref","unstructured":"Mohyeldin RH, Sharata EE, Fawzy MA, Attya ME, Welson NN, Rofaeil RR (2025) Memantine abrogates testicular dysfunction induced by risperidone in rats with a potential role of ERK1\/2-Nrf2-caspase-3 signaling pathway. Sci Rep [Internet]. 15(1):12914. Available from: https:\/\/www.nature.com\/articles\/s41598-025-94760-1","DOI":"10.1038\/s41598-025-94760-1"},{"key":"5683_CR148","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.987293","author":"H Zhang","year":"2023","unstructured":"Zhang H, Wang L, Yang Y, Cai C, Wang X, Deng L et al (2023) DL-3-n-butylphthalide (NBP) alleviates poststroke cognitive impairment (PSCI) by suppressing neuroinflammation and oxidative stress. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.987293","journal-title":"Front Pharmacol"},{"key":"5683_CR149","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.355815","author":"HY Zhang","year":"2023","unstructured":"Zhang HY, Jiang YC, Li JR, Yan JN, Wang XJ, Shen JB et al (2023) Neuroprotective effects of insulin-like growth factor-2 in 6-hydroxydopamine-induced cellular and mouse models of Parkinson\u2019s disease. Neural Regen Res. https:\/\/doi.org\/10.4103\/1673-5374.355815","journal-title":"Neural Regen Res"},{"key":"5683_CR150","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-50144-x","author":"C Wang","year":"2023","unstructured":"Wang C, Ouyang S, Zhu X, Jiang Y, Lu Z, Gong P (2023) Myricetin suppresses traumatic brain injury-induced inflammatory response via EGFR\/AKT\/STAT pathway. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-023-50144-x","journal-title":"Sci Rep"},{"key":"5683_CR151","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddx093","author":"D Moujalled","year":"2017","unstructured":"Moujalled D, Grubman A, Acevedo K, Yang S, Ke YD, Moujalled DM et al (2017) TDP-43 mutations causing amyotrophic lateral sclerosis are associated with altered expression of RNA-binding protein hnRNP K and affect the Nrf2 antioxidant pathway. Hum Mol Genet. https:\/\/doi.org\/10.1093\/hmg\/ddx093","journal-title":"Hum Mol Genet"},{"key":"5683_CR152","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087398","author":"SR Shepheard","year":"2014","unstructured":"Shepheard SR, Chataway T, Schultz DW, Rush RA, Rogers ML (2014) The extracellular domain of neurotrophin receptor p75 as a candidate biomarker for amyotrophic lateral sclerosis. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0087398","journal-title":"PLoS One"},{"key":"5683_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2017.02.019","author":"A Bhinge","year":"2017","unstructured":"Bhinge A, Namboori SC, Zhang X, VanDongen AMJ, Stanton LW (2017) Genetic correction of SOD1 mutant iPSCs reveals ERK and JNK activated AP1 as a driver of neurodegeneration in amyotrophic lateral sclerosis. Stem Cell Rep. https:\/\/doi.org\/10.1016\/j.stemcr.2017.02.019","journal-title":"Stem Cell Rep"},{"key":"5683_CR154","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-022-03013-z","author":"Y Qi","year":"2022","unstructured":"Qi Y, Yang C, Zhao H, Deng Z, Xu J, Liang W et al (2022) Neuroprotective effect of sonic hedgehog mediated PI3K\/AKT pathway in amyotrophic lateral sclerosis model mice. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-022-03013-z","journal-title":"Mol Neurobiol"},{"key":"5683_CR155","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10061307","author":"D Lanznaster","year":"2022","unstructured":"Lanznaster D, Bruno C, Bourgeais J, Emond P, Zemmoura I, Lef\u00e8vre A et al (2022) Metabolic profile and pathological alterations in the muscle of patients with early\u2010stage amyotrophic lateral sclerosis. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10061307","journal-title":"Biomedicines"},{"key":"5683_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2014.05.035","author":"S Abdulla","year":"2014","unstructured":"Abdulla S, Machts J, Kaufmann J, Patrick K, Kollewe K, Dengler R et al (2014) Hippocampal degeneration in patients with amyotrophic lateral sclerosis. Neurobiol Aging. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.05.035","journal-title":"Neurobiol Aging"},{"key":"5683_CR157","doi-asserted-by":"publisher","unstructured":"El-Eraky El-Azab N, M. El-Mahalaway A, Sabry D (2018) Effect of methyl mercury on the cerebellar cortex of rats and the possible neuroprotective role of mesenchymal stem cells conditioned medium. Histological and immunohistochemical study. J Gastrointest Cancer Stromal Tumors 8(06). https:\/\/doi.org\/10.4172\/2572-4126.1000430","DOI":"10.4172\/2572-4126.1000430"},{"key":"5683_CR158","doi-asserted-by":"publisher","unstructured":"Cambier S, Gonzalez P, Mesmer-Dudons N, Br\u00e8thes D, Fujimura M, Bourdineaud JP (2012) Effects of dietary methylmercury on the zebrafish brain: histological, mitochondrial, and gene transcription analyses. Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 25(1), 165\u2013180. https:\/\/doi.org\/10.1007\/s10534-011-9494-6","DOI":"10.1007\/s10534-011-9494-6"},{"key":"5683_CR159","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1999.tb00717.x","author":"I Niebroj-Dobosz","year":"1999","unstructured":"Niebroj-Dobosz I, Janik P (1999) Amino acids acting as transmitters in amyotrophic lateral sclerosis (ALS). Acta Neurol Scand. https:\/\/doi.org\/10.1111\/j.1600-0404.1999.tb00717.x","journal-title":"Acta Neurol Scand"},{"key":"5683_CR160","doi-asserted-by":"publisher","unstructured":"Berry JD, Cudkowicz ME, Windebank AJ, Staff NP, Owegi M, Nicholson K, McKenna-Yasek D, Levy YS, Abramov N, Kaspi H, Mehra M, Aricha R, Gothelf Y, Brown RH (2019) NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results. Neuro 93(24), e2294\u2013e2305.\nhttps:\/\/doi.org\/10.1212\/WNL.0000000000008620","DOI":"10.1212\/WNL.0000000000008620"},{"key":"5683_CR161","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2019.1632346","author":"JS Mora","year":"2020","unstructured":"Mora JS, Genge A, Chio A, Estol CJ, Chaverri D, Hern\u00e1ndez M et al (2020) Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial. Amyotroph Lateral Scler Frontotemporal Degener. https:\/\/doi.org\/10.1080\/21678421.2019.1632346","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"5683_CR162","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149509","author":"E Nagata","year":"2016","unstructured":"Nagata E, Ogino M, Iwamoto K, Kitagawa Y, Iwasaki Y, Yoshii F et al (2016) Bromocriptine mesylate attenuates amyotrophic lateral sclerosis: a phase 2a, randomized, double-blind, placebo-controlled research in Japanese patients. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0149509","journal-title":"PLoS One"},{"key":"5683_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2008.01.009","author":"GN Babu","year":"2008","unstructured":"Babu GN, Kumar A, Chandra R, Puri SK, Singh RL, Kalita J et al (2008) Oxidant-antioxidant imbalance in the erythrocytes of sporadic amyotrophic lateral sclerosis patients correlates with the progression of disease. Neurochem Int. https:\/\/doi.org\/10.1016\/j.neuint.2008.01.009","journal-title":"Neurochem Int"},{"key":"5683_CR164","doi-asserted-by":"publisher","DOI":"10.1006\/neur.1996.0008","author":"S Przedborski","year":"1996","unstructured":"Przedborski S, Donaldson DM, Murphy PL, Hirsch O, Lange D, Naini AB et al (1996) Blood superoxide dismutase, catalase and glutathione peroxidase activities in familial and sporadic amyotrophic lateral sclerosis. J Neurodegener Dis. https:\/\/doi.org\/10.1006\/neur.1996.0008","journal-title":"J Neurodegener Dis"},{"key":"5683_CR165","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2016.284","author":"H Blasco","year":"2017","unstructured":"Blasco H, Garcon G, Patin F, Veyrat-Durebex C, Boyer J, Devos D et al (2017) Panel of oxidative stress and inflammatory biomarkers in ALS: a pilot study. Can J Neurol Sci. https:\/\/doi.org\/10.1017\/cjn.2016.284","journal-title":"Can J Neurol Sci"},{"key":"5683_CR166","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2010.02.004","author":"E Cova","year":"2010","unstructured":"Cova E, Bongioanni P, Cereda C, Metelli MR, Salvaneschi L, Bernuzzi S et al (2010) Time course of oxidant markers and antioxidant defenses in subgroups of amyotrophic lateral sclerosis patients. Neurochem Int. https:\/\/doi.org\/10.1016\/j.neuint.2010.02.004","journal-title":"Neurochem Int"},{"key":"5683_CR167","doi-asserted-by":"publisher","DOI":"10.3109\/21678421.2015.1026826","author":"Z Macchi","year":"2015","unstructured":"Macchi Z, Wang Y, Moore D, Katz J, Saperstein D, Walk D et al (2015) A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: possible mitochondrial biomarker target engagement. Amyotroph Lateral Scler Frontotemporal Degener. https:\/\/doi.org\/10.3109\/21678421.2015.1026826","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"5683_CR168","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40734-8","author":"J Mandrioli","year":"2023","unstructured":"Mandrioli J, D\u2019Amico R, Zucchi E, De Biasi S, Banchelli F, Martinelli I et al (2023) Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-023-40734-8","journal-title":"Nat Commun"},{"key":"5683_CR169","doi-asserted-by":"publisher","unstructured":"Beghi E, Pupillo E, Bianchi E, Bonetto V, Luotti S, Pasetto L, Bendotti C, Tortarolo M, Sironi F, Camporeale L, Sherman AV, Paganoni S, Scognamiglio A, De Marchi F, Bongioanni P, Del Carratore R, Caponnetto C, Diamanti L, Martinelli D, Calvo A (2023) Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial. European journal of neurology, 30(1), 69\u201386. https:\/\/doi.org\/10.1111\/ene.15573","DOI":"10.1111\/ene.15573"},{"key":"5683_CR170","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300573R","author":"K Zamiri","year":"2023","unstructured":"Zamiri K, Kesari S, Paul K, Hwang SH, Hammock B, Kaczor-Urbanowicz KE et al (2023) Therapy of autoimmune inflammation in sporadic amyotrophic lateral sclerosis: dimethyl fumarate and H-151 downregulate inflammatory cytokines in the cGAS-STING pathway. FASEB J. https:\/\/doi.org\/10.1096\/fj.202300573R","journal-title":"FASEB J"},{"key":"5683_CR171","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-007-9564-x","author":"GN Babu","year":"2008","unstructured":"Babu GN, Kumar A, Chandra R, Puri SK, Kalita J, Misra UK (2008) Elevated inflammatory markers in a group of amyotrophic lateral sclerosis patients from northern India. Neurochem Res. https:\/\/doi.org\/10.1007\/s11064-007-9564-x","journal-title":"Neurochem Res"},{"key":"5683_CR172","doi-asserted-by":"publisher","unstructured":"Jeyachandran A, Mertens B, McKissick EA, Mitchell CS (2015) Type I Vs. Type II Cytokine Levels as a Function of SOD1 G93A Mouse Amyotrophic Lateral Sclerosis Disease Progression. Front Cell Neurosci 9:462. https:\/\/doi.org\/10.3389\/fncel.2015.00462","DOI":"10.3389\/fncel.2015.00462"},{"key":"5683_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102844","author":"W Camu","year":"2020","unstructured":"Camu W, Mickunas M, Veyrune JL, Payan C, Garlanda C, Locati M et al (2020) Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): a phase 2a randomised, double-blind, placebo-controlled trial. EBioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102844","journal-title":"EBioMedicine"},{"key":"5683_CR174","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0267183","author":"A Logan","year":"2022","unstructured":"Logan A, Nagy Z, Barnes NM, Belli A, Di Pietro V, Tavazzi B et al (2022) A phase II open label clinical study of the safety, tolerability and efficacy of ILB\u00ae for amyotrophic lateral sclerosis. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0267183","journal-title":"PLoS One"},{"key":"5683_CR175","unstructured":"Kononets O, Karaiev T, Lichman L, Kucher O (2022) Monitoring of renal, hepatic and immune function indices in patients with neuromuscular disorders: amyotrophic lateral sclerosis and Duchenne muscular dystrophy. Georgian Med News\u00a0(322), 131\u2013139"},{"key":"5683_CR176","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i36.10475","author":"M Salvado","year":"2015","unstructured":"Salvado M, Vargas V, Vidal M, Simon-Talero M, Camacho J, Gamez J (2015) Autoimmune-like hepatitis during masitinib therapy in an amyotrophic lateral sclerosis patient. World J Gastroenterol. https:\/\/doi.org\/10.3748\/wjg.v21.i36.10475","journal-title":"World J Gastroenterol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05683-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05683-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05683-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T06:29:46Z","timestamp":1770359386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05683-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":176,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5683"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05683-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was carried out in accordance with the Institutional Animal Ethics Committee (IAEC) norms, with registration number 816\/PO\/ReBiBt\/S\/04\/CPCSEA 06\/08\/2004 as ISFCP\/IAEC\/CCSEA\/Meeting No: 06\/2024\/Protocol No. 54 approved by the RAB Committee, ISFCP, Moga, Punjab, India.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors approve of submitting the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"422"}}